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Multiple lesion transluminal coronary angioplasty was
performed in 428 patients. Angioplasty was attempted
in 1,047 lesions (2.4/patient), with an angiographic suc-
cess achieved in 94%: 2 lesions were attempted in 74%,
3 in 21%, 4 in 5% and 5 or more in I % of cases. A
clinical successwasachieved in 404 (94%) of the patients:
95% with and 93% without prior surgery and in 94%
of those with single vessel disease and 94% of those with
multivessel disease. Significant complications occurred
in 17 patients (4.0%): 11 (2.5%) had a transmural in-
farction, 9 (2.1%) required urgent surgery and 6 (1.4%)
died. An apparent lesion recurrence occurred in 106
(26%) of 404 patients with 81 of 89 patients (91%) having
a successful second angioplasty. A second apparent le-
sion recurrence occurred in 15 patients (19%), with 13
Percutaneous transluminal coronary angioplasty (I) has be-
come an effective alternative to medical management or
myocardial revascularization surgery, or both, in selected
patients with obstructive coronary artery disease. The dem-
onstrated safety and efficacy of angioplasty in patients with
one or more isolated proximal coronary stenoses (2) allowed
evaluation of this procedure in patients with extensive coro-
nary artery disease (3-12). This study examines the short-
and long-term follow-up of patients who underwent multiple
lesion angioplasty.
Methods
Study patients (Table 1). The data are derived from
428 consecutive patients who underwent multiple lesion
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of the 15 patients having a successful third angioplasty.
A sustained clinical improvement (mean follow-up
period 28.3 ± 16 months) was obtained in 208 (83%)
of 250 patients with successful angioplasty. The cumu-
lative probability of survival at 51 months was 93% in
these 250 patients. Survival was adversely affected by
the presence of prior bypass surgery (no prior surgery
97% versus prior surgery 81%; P < 0.05).
These data suggest that multiple lesion angioplasty
can be successfully performed with a good success rate,
an acceptable incidence of complications and a reason-
able expectation of satisfactory long-term clinical im-
provement.
(1 Am Coli Cardiol 1987;10:1007-13)
angioplasty between February 1979 and April 1986 (86
months) at our institution. All data were collected in a pro-
spective manner in all patients undergoing multiple vessel
angioplasty, including those with left main coronary artery
disease (with or without prior bypass surgery), multiple prior
bypass operations, cardiogenic shock or severe concomitant
medical illness. The patients either had significant angina
pectoris or had no or minimal angina (13) with significant
documented myocardial ischemia. Their clinical character-
istics are listed in Table 1. Sixteen of the patients underwent
angioplasty of different vessels during the same hospital-
ization (staged procedure).
The population studied represents the personal experi-
ence of all consecutive cases performed by the senior author
(G.D.), and does not represent the experience of all phy-
sicians performing angioplasty at St. Luke's Hospital. The
data represent 42% of all cases performed during the same
time period. The proportion of cases in which multi lesion
angioplasty was performed increased over the years as more
experience was gathered and better equipment became avail-
able.
Anatomic factors. The patient's coronary anatomy (that
IS, the site of the stenosis or stenoses determined by the
0735-1097/87/$3.50
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Table 1. Characteristics of 428 Patients Undergoing Multiple
Lesion Angioplasty
*Sixteen patients underwent two procedures during the same hospi-
talization to achieve the multiple dilations; tCanadian Cardiovascular So-
ciety classification.
coronary cinearteriograms) was the primary determinant of
whether angioplasty could be attempted. The definitions of
single vessel disease (2), multi vessel disease (4), lesion
significance (2), techniques (2,4,14) and complications
(14-16) have been reported.
In patients with multiple lesion angioplasty, the signifi-
cant culprit lesion (or lesions) was considered to be acces-
sible to the angioplasty catheter. Selected individuals under-
went angioplasty of multiple lesions despite the presence of
significant disease in other coronary vessels. These latter
diseased vessels were not dilated because they were either
occluded or of such small caliber or poor condition (diffusely
diseased, that is, on cineangiography, the vessel appeared
to be small, the luminal wall appeared to be irregular with
multiple noncritical narrowings or the vessel had a beaded
appearance) that they were considered unsuitable for any
intervention (either angioplasty or bypass surgery). In this
group of patients, if the stenosis (or stenoses) considered
critical (culprit lesion or lesions) was successfully dilated,
the patient was considered to be amenable to medical man-
agement despite incomplete revascularization.
Lesion severity was estimated by visual assessment of
the percent diameter stenosis obtained in multiple views
before and after angioplasty. Hemodynamic assessment of
lesion severity was ascertained by measurement of the mean
transstenotic pressure gradient.
Patient selection. Selected patients (17%) preferentially
underwent angioplasty because they were anticipated to have
a prohibitively high surgical risk (morbidity or mortality,
Patients*
Men
Women
Age (yr)
Extent of coronary disease
Single vessel
Multivessel
Left ventricular ejection fraction ,s35%
Prior bypass surgery
Anginal classt
Class 0 (no angina)
Class I
Class II
Class III
Class IV
Prior myocardial infarction (documented)
Diabetes mellitus
Hypertension
Prior stroke
Chronic renal failure
Chronic obstructive lung disease
428
333 (78%)
95 (22%)
58.8
69 (16%)
359 (84%)
22 (5%)
115 (27%)
63 (15%)
52 (12%)
150 (35%)
103 (24%)
61 (14%)
201 (47%)
57 (13%)
176 (41%)
12 (2.8%)
7(1.6%)
12 (2.8%)
or both, in light of their medical history and clinical status,
the presence of multiple prior operations [12%], a func-
tioning internal mammary artery graft or grafts [1.8%], con-
comitant severe, debilitating medical conditions, a recent
myocardial infarction complicated by severe congestive heart
failure [1%], cardiogenic shock [I %] or severe left ven-
tricular dysfunction [5%]).
These patients were preferentially referred for multiple
lesion angioplasty because they were in clinically unstable
condition after recent (days to weeks) bypass surgery, they
were not a candidate for reoperation, there were no obvious
vein graft donor sources, the significant lesion (or lesions)
was in a vessel that had undergone endarterectomy, or it
was hoped that the procedure would avoid the need for future
valve replacement. These high risk patients agreed to at-
tempted angioplasty with the realization that intraaortic bal-
loon counterpulsation would be utilized if necessary, but
that immediate myocardial revascularization would be avoided
or not performed under any circumstance.
Technical considerations and approach. Each patient
was maintained on an antiplatelet aggregation regimen of
aspirin (325 rug/day) and dipyridamole (150 mg/day) for I
or 2 days before and indefinitely after the procedure. Treat-
ment with a calcium channel antagonist (nifedipine, 30 mg,
or diltiazem, 120 mg, daily) was initiated the day before
and empirically continued for I week after angioplasty un-
less clinically required longer. All patients received heparin
(10,000 to 15,000 IV), nitroglycerin ointment and sublin-
gual nitroglycerin at the beginning of the procedure. Intra-
coronary nitroglycerin was rarely utilized. The cardiovas-
cular surgical team was aware of all patients; however, since
1982, the operating theater has not been reserved for pos-
sible emergency use during the procedure itself.
Inmultiple lesion angioplasty the first dilation attempted
was that of the stenosis considered critical (that is, the culprit
lesion or the lesion that was the presumptive cause of the
patient's problems). Only after successful dilation of the
culprit lesion was angioplasty of additional stenoses of less
importance attempted. However, when a severely diseased
vessel supplied collateral flow to another diseased vessel,
then the collateralized vessel was dilated initially to protect
the collateral blood supply. Angioplasty of subsequent sig-
nificant lesions of less critical importance was attempted
only when the preceding critical lesions were satisfactorily
dilated. If a problem arose during the procedure or the
angiographic appearance of the dilation was not satisfactory,
the procedure was terminated. The patient was observed in
an intensive care setting and received intravenous heparin
(1,000 IV/h) and intravenous nitroglycerin (15 to 20 J,Lg/min)
for 8 to 12 hours. If indicated, another procedure was then
scheduled. This approach was instituted to lessen the extent
of myocardial ischemia should vessel occlusion occur.
Definitions. Multiple lesion angioplasty was defined as
the dilation of two or more discrete lesions in varying com-
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binations of two or more coronary vessels, vein grafts, in-
ternal mammary artery grafts or different segments of the
same vessel. Multiple lesion angioplasty included the di-
lation of tandem (sequential) lesions in different segments
of the same vessel (for example, proximal and distal seg-
ments of the left anterior descending coronary artery, prox-
imal right coronary artery and distal posterior descending
artery) when they were separated by an angiographically
lesion-free segment.
A multiple dilation procedure WllS considered success/iii
when all attempted dilations were successfully (a 2:20%
Table 2. Summary of 428 Multiple Lesion
Angioplasty Procedures
Angioplasty attempts (no. of lesions)
No. of lesions attempted per patient
2
3
4
5
Vessel dilated
Left anterior descending coronary artery
Left circumflex coronary artery
Right coronary artery
Left main coronary artery
Vein gran
Successes
Successes/total lesions
Successes/total patients
In cases without prior bypass surgery
ln cases with prior bypass surgery
In single vessel corondry disease
in multivessel coronary disease
Reasons for unsuccessful dilations
Inability to cross the lesion with guide wire
or dilation catheter
Lesion rigidity
Vessel dissection/occlusion before balloon
inflation
Other
J .047
74'!r
21%
< 5%
< 1%
44f! (42%)
:?33 (22%)
25X (25%)
10(1 %)
100 (lO'le)
\lX5 of 1.047 (94'!r)
404 of 428 (940/< )
307 of 324 (950/< )
II J of 120 (930/< )
65 of f!\l (\l40/< )
353 of 375 (94'!r )
49
f!
5
2
reduction in percent diameter stenosis) or when only the
culprit lesion (or lesions) was successfully dilated, and when
these angiographically successful results were accompanied
by a clinical improvement within I week of the procedure.
The mean transstenotic pressure gradient was not measured
in all lesions and, therefore, was not utilized within the
definition of success. Clinical improvement (by two or more
Canadian Cardiovascular Society functional classes) was
evaluated by the patient' s subjective assessment of anginal
status or by noninvasive techniques, or both. An apparent
symptom-related lesion recurrence was considered to be
present when clinical improvement manifested after angie-
plasty began to deteriorate in association with angiographic
evidence of restenosis of one or more lesions, disease pro-
gression or new lesion development.
The definitions of transmural myocardial infarction,
coronary spasm, coronary occlusion and emergency bypass
surgery were consistent with those utilized by the National
Heart. Lung, and Blood Institute PercutaneousTransluminal
Coronary Angioplasty Registry Manual (2).
Follow-up data. Follow-up data on all patients (with
successful or unsuccessful angioplasty) were obtained by
periodic (within I week. at 3 and 6 months and yearly)
interviews conducted during office visits or by telephone
calls or written questionnaires. These interviews provided
information on the patient' s vital status, anginal status. oc-
currence of a myocardial infarction. repeat hospitalization
or the need for subsequent angioplasty or bypass surgery.
A late death was defined as a death that occurred after
hospital discharge. At a mean follow-up time of 28.3 :t
16 months, data regarding vital status and subsequent bypass
surgery were obtained in 98(1(1 of patients; data on anginal
status were obtained in 92°k .
Statistical analysis. All data are presented as the mean
value :t I standard deviation. The chi-square test with
Yates" correction was utilized to determine differences be-
tween groups in relation to long-term follow-up (univariate
Table 3. Corona ry Vessel Combinations in Multipl e Lesion Angioplasty
Vessels Attempted
LAD + Diag
LAD + RCA
LAD + LCx
RCA + LCx
LMCA + RCA/LCA/SVG*
SVG + LCA/RCA/SVGt
> 2 lesions dilated
Lesion Successes per
Total Lesion Attempts
75 of XO (94'k)
115 of 12X (90'k)
103 of 10f! (97'7c)
49 of 52 (94 'k )
10 01' 12 (X3'7c)
72 of RX (X2Ck)
26f! of :?72 (9W!r )
Case Successes
per Total Cases
38 of 40 (95%)
60 of 64 (940/< )
48 of 53 (910/< )
25 of 26 (96'7c,)
5 of 6 (X3Ck )
38 of 44 (X6'k)
77 of XO (96ck )
*Left main coronary artery lesion and right coronary or left coronary or vein g.raft lesion: lSaphenous vein
graft lesion and left coronary or right coronary or another vein graft lesion. Diag .,~ diagonal branch: LAD ~
left anterior descending coronary artery; LCA = left coronary artery: LCx = left circumtlex coronary artery:
LMCA = left main coronary artery; RCA = right coronary artery: SVG = saphenous vein graft: more than
two lesions dilated = lesions in different vessels or in conjunction with lesions in different segments of the
same vessel. or both.
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Table 4. Complications* Encountered During Multiple Lesion
Angioplasty in 428 Patients
*Complications listed were not mutually exclusive and multiple com-
plications often were encountered in the same patient; 361 (84%) of the
428 patients had no complication and 17 patients (4.0%) experienced a
significant complication. t AlI six deaths occurred in patients without prior
coronary bypass surgery.
analy sis). Variables included age , left ventricular function
and history of prior bypass surgery. A probability (p) value
of < 0.05 was considered statistically significant. Life table
analysis was performed according to previously publ ished
methods (17).
Transmural myocardial infarction
Coronary spasm
Coronary occlusion
Monalityt
Emergency bypass surgery
No.
II
26
16
6
9
%
(2 .5%)
(6.0'70)
(3.7 %)
(1.4 %)
(2. 1%)
Results
Angioplasty procedure (Tables 2 and 3). An angio-
graphic success was achieved in 94% of the 1,047 lesions.
and clinical improvement occurred in 94% of the 428 pa-
tients. Mean percent stenosis diameter was reduced from
82 ± 13 to 17 ± 21% and mean transstenotic pressure
gradient from 47 ± 18 to 7 ± 8 mm Hg before and after
angioplasty. The final residual stenosis was < 50% in 97%
of lesions, and between 50 and 60% in 3% of lesions. The
mean maximal balloon inflation pressure was 8.3 ± 1.5
barrs for a mean time of 0.9 ± 0.2 minutes. The mean
number of inflations per lesion was 3.2 ± 2.2. Table 3 lists
the combinations of dilation s attempted, successful dilations
and patient successes. No statistically significant differences
were found in success rates among the vessels attempted
(or different patient subgroups).
Complications (Table 4). A significant complication
(death, emergency surgery or transmural myocardial in-
farction) occurred in 17 (4%) of the 428 patient s. There
were six in-hospital deaths (mortality rate 1.4%). None of
Table 5. Clinical Status ?: I Year After Successful Multiple Lesion Coronary Angioplasty
Mean time from first angioplasty to last contact (mo) (for patients > I yr after angioplasty)
Mean average time from last contact (mo)
Successful patient follow-up a I year after angioplasty
Patient data
Total no. of patients
Patients < 12 mo after angioplasty
Patients > 12 mu with no follow-up of anginal status
Patients* > 12 mo after successful angioplasty
Patients who underwent bypass surgery after successful first angioplasty
Patients excluded because of death or subsequent bypass surgery
Clinical patient data (> 12 mo after successful angioplasty)
Patients with angina reported at time of angioplasty
Angina frequency at latest follow-up
None
I time/wk
I to 2 tirnes/mo
Daily
No recordt
Anginal status since angioplasty
Less
Wurse
Same
No record
Patients with no angina reported at time of angiuplasty
Angina frequency at latest follow-up
None
I time/wk
I to 2 times/me
Daily
No recurd
Late deaths
Total number
Cardiac related
28.3 ± 16
6.2 ± 6.7
92%
428
11 3
25
250
25
40
208 (83% )
141 (68%)
18
39
6
2
173 (83%)
7
10
18
42 ( 17%)
35 (83%)
I
6
o
o
14
12
*Excludes patients who subsequently died or underwent bypass surgery during follow-up: tno record
indicates that the patient is known to be alive, but failed or refused to answer questionnaire .
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the six patients had had prior bypass surgery. All six patients
had undergone apparently successful angioplasty (that is,
the angioplasty was carried out without incident) and the
postangioplasty cinearteriograms showed successful dila-
tions. Five of the six patients who died had a coronary
occlusion (four patients within 30 minutes of angioplasty,
and one patient 6 hours after angioplasty). Three patients
who died underwent emergency bypass surgery on the day
that angioplasty had been performed. In each case, visual
inspection of the heart revealed no gross evidence of coro-
nary dissection, vessel rupture, epicardial hematoma or
intracoronary thrombus. These findings coupled with the
cinearteriograms, which showed no intimal tear or disrup-
tion, gave credence to the presumption that the coronary
occlusion may have been the resultof severe coronary spasm
or an intramural hemorrhage.
The complications encountered were not mutually ex-
clusive' with multiple complications occurring in the same
patient. Three patients who died had evidence of an acute
transmural myocardial infarction.
Follow-up (Table 5). There were 250 patients with suc-
cessful angioplasty alive and without subsequent bypass
surgery > 12 months after their initial angioplasty proce-
dure. Follow-up of patients who had angina at the time of
angioplasty showed that 68% had no and 83% had less
angina at the time of the last contact. There were 14 late
deaths, of which 12 were ascribed (on the death certificate)
to atherosclerotic heart disease.
A first apparently symptom-related lesion recurrence (Fig.
1) occurred at a mean time of 6.6 months in 106 patients
(26%). A second angioplasty was attempted in 89 of these
patients, and was successful in 81 (91%). It was unsuc-
cessful in eight: one of these patients died, one underwent
emergency surgery, five underwentelective surgery and one
patient was medically treated. A second apparent symptom-
related lesion recurrence occurred at a mean time of 11.3
months in 15 (19%) of the 81 patients who had undergone
a second angioplasty. A third angioplasty was successful in
13 of these 15 patients; the remaining 2 patients underwent
elective bypass surgery.
Life table analysis. The long-term survival of 404 pa-
tients after successful multiple lesion angioplasty was eval-
uated using the life table method (Fig. 2). The longest pa-
tient follow-up is 87 months. The sample size (n = 6\)
was sufficient at 5\ months to show a 0.93 probability of
survival (standard error = 0.019). Univariate analysis at
51 months showed survival to be adversely affected by the
presence of prior surgery (no prior surgery 97% versus prior
surgery 81 %; P < 0.05). When death or postangioplasty
surgery (Fig. 3) was used as the marker, at 51 months the
probability was 88% that a patient would be alive and would
not have undergone surgery. Univariate analysis showed
that the probabilityof being alive and not having undergone
surgery was adversely affected by the presence of prior
surgery (no prior surgery 94% versus prior surgery 72%; p
< 0.05).
Discussion
Success rate. The data base consisted of data from all
patients who underwent multiple lesion angioplasty between
February 1979 and April \986. The technique utilized to
perform angioplasty before 1983 involved utilization of a
fixed wire catheter system and, subsequent to 1983, the
steerable, movable wire dilation catheter systems that have
undergone considerable modification since that time. A
comparison of the data from cases in which angioplasty was
performed before 1983 (67 cases) with those in which it
was performedafter \983 (361 cases) showed no statistically
significantdifference in patientclinical characteristics, mean
number of lesions dilated per case, angiographic success
rate, patient clinical success rate and complication rate.
However, the lack of statistical differences does not take
into account the technologic advances (that is, lower profile,
higher pressure, more trackable dilation catheters coupled
with the softer, steerable guide wire systems) that enabled
more difficult. unusual and challenging cases to be suc-
cessfully managed. These changes ultimately affected the
Figure I. Results of follow-up of 428 patients (PTS) who under-
went multiple lesion coronary angioplasty (PTCA). CABG =
coronary artery bypass graft; LR = apparent symptom-related
lesion recurrence; MED = medical treatment; NR = noapparent
symptom-related lesion recurrence; S = successful; UN = un-
successful.
428 PTS
S~UN
404 PTS (94%) I '"
24 PTS (6%)
NR~ lSTLR
I ~ 106 PTS (26%)
312 PTS (74%) 'cAA 2NI
NO PTi ~D PTCA
17 PTS 89 PTS
~N
81 PTS (91%) 8 PT/~ g::~Hl
'R />: 2NI L~ MED J
N; ~DLR
66 PTS 15 PTS (19%)
~RDPTCA
15 PTS
~
13 PTS 2 PTS (2 CABG)
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Figure 2. Life table actuarial analysisof mortality in 428 patients
who underwent successful multiple lesion angioplasty. The num-
bers above the horizontal line represent the patients at risk at the
end of each 6 month period. CABO = coronary artery bypass
graft; CUMM. PROB. SURV. = cumulative probability of sur-
vival.
selection criteria, and this factor cannot be appreciated by
looking only at the statistical analysis.
The success rates reported herein were similar to some
published data (3-5,8) and higher than in the National Heart,
Lung, and Blood Institute Percutaneous Transluminal Coro-
nary Angioplasty Registry report (2). The 94% angiographic
success rate produced a significant clinical improvement in
94% of the patients. This clinical success appeared to be
related to the successful dilation of the culprit lesion (or
lesions) and not to the presence of single or multivessel
coronary disease or history of prior bypass surgery. The
major complications encountered were comparable with those
in published reports (12), and were not increased despite
the increased number of patients with multi vessel coronary
artery disease (84% in our series) and the potentially high
risk surgical patients (patients with severe left ventricular
dysfunction [5.0%1. prior stroke [2.7%1. chronic renal fail-
ure [1.6%], severe chronic obstructive lung disease [2.7%]
or prior coronary bypass surgery [27%]).
Complications of angioplasty procedure. The sudden
loss or diminution of coronary blood ftow resulting from
coronary spasm, intraluminal thrombus, intramural hem-
orrhage or coronary dissection with a partially or totally
obstructing intimal ftap may result in profound left ventric-
ular dysfunction, which may not be adequately or success-
fully managed by any form of intervention including emer-
gency myocardial revascularization surgery (16). Presumably,
patients with multivessel coronary artery disease who undergo
404 314 288 213 195 138 127 85 78 51 42 33
6 12 18 24 30 36 42 48 54 60 66
No Prior CABG N=308
Overall N-42B
Prior CA8G N-120
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Figure 3. Actuarial analysis of events (death or subsequent coro-
nary bypass surgery) in patients who underwent multiple lesion
angioplasty. The numbers above the horizontal line represent the
patients at risk at the end of each 6 month period. Abbreviations
as in Figure 2.
.,
angioplasty with an increased potential for sudden simul-
taneous development of multiple areas of myocardial isch-
emia have less myocardial function reserve than that of
patients with single vessel disease undergoing single vessel
dilation .
From our viewpoint, the best therapeutic approach in
such cases, after alerting the cardiovascular surgeon, was
immediate percutaneous introduction of the intraaortic bal-
loon pump and attempted recanalization of the occluded
vessel (or vessels) with angioplasty or subsequent insertion
of a coronary artery perfusion catheter beyond the occlusion
into the distal vessel. This may permit stabilization of the
patient's condition and either obviate the need for emer-
gency surgery or enable the patient to reach the surgical
suite in a more stable state .
If the planned angioplasty procedure did not go smoothly
or the results of a particular dilation were not visually sat-
isfactory, any contemplated additional angioplasty attempts
were aborted. Subsequent dilations were not performed, no
matter how "easy" they appeared to be.
Follow-up. At follow-up, 106 (26%) of the 404 patients
who had undergone successful multi vessel angioplasty had
had an apparent symptom-related lesion recurrence. In al-
most all instances, the decision not to send the patient for
repeat angioplasty was made by the referring physician or
the patient, or both. Nevertheless, 82 (92%) of the 89 pa-
tients (81 with repeat angioplasty, I with medication) were
managed without the need for subsequent surgery. Thus,
379 (94%) of the 404 patients who had undergone successful
Prior CA8G N-120
No Prior CABG N=308
Overall N-42B
MONTHS
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angioplasty continued to be managed without the need for
subsequent surgery at a mean follow-up time of 28.3 ± 16
months.
Life table analysis of successful multiple lesion angio-
plasty in our patients showeda 93% probabilityof surviving
51 months (n = 61 patients) after the initial procedure .
Survival was adversely affected by the presence of prior
coronary bypass surgery. Similarly, the presence of prior
surgery increased the likelihood of subsequently undergoing
postangioplasty bypass surgery. Thus, patients with prior
surgery who have progressionof the atherosclerotic process
(18) have a lower survival rate. despite successful angio-
plasty, but also an increasedlikelihoodof undergoing repeat
surgery rather than repeat angioplasty.
Conclusions. Patients with multiplecoronary artery ste-
noses. the majorityof whomhad multivessel coronaryartery
disease. underwent multiple vessel angioplasty of varying
combinations of arterial or vein graft stenoses. Angioplasty
was successful in dilating 94% of the multiple lesions. and
achieved a clinical improvement in 94% of the patients. The
significant complications encountered included death (1.4%),
transmural infarction (2.5%) and emergency surgery (2. ) % ).
A sustained clinical improvement was obtained in 83% of
patients undergoing angioplasty with or without the neces-
sity for repeat angioplasty or medication. The anginal status
in 83% of patients with angina before angioplasty was im-
proved 2: 12 months after angioplasty. Life table analysis
showed a 93% survival at 51 months, which was adversely
affected by the presence of prior bypass surgery. In addition.
the probability was 88% that at 51 months, a patient would
be alive and not have undergone subsequent bypass surgery.
Further evaluation of this extended application of coronary
angioplasty is necessary to establish its role in the therapy
of extensive coronary artery disease.
We express our sincere thanks to Carol Riegelhaupt for secretarial assis-
tance and manuscript typing. Marla Engel for data management and patient
follow-up and Michael Rohan for computer programming.
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